Insight

Impact of Hormone Receptor Status in Young BRCA Carriers

Photo from Luca Arecco/X

Jun 23, 2024, 18:54

Impact of Hormone Receptor Status in Young BRCA Carriers

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: .

“Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers – Annals of Oncology

•In young BRCA carriers, hormone receptor status did not appear to be a strong positive prognostic factor.
• Patients with luminal A-like disease seem to have the worst DFS compared to all the other subtypes.
• Personalized treatment, surveillance, and prevention strategies based on disease biology are recommended in young BRCA carriers.”

Source: Elisabetta Bonzano/X

BRCA carriers BRCA genes cancer Hormone Receptor Status IRCCS San Matteo Polyclinic Foundation luminal A-like disease OncoDaily Oncology personalized treatment prevention strategies surveillance

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage